av/medistim-asa--big.svg

COM:MEDISTIM

Medistim

  • Stock

Last Close

133.50

22/11 12:31

Market Cap

3.21B

Beta: -

Volume Today

196

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
37.05M
-
37.40M
0.94%
41.74M
11.61%
52.95M
26.86%
61.01M
15.21%
63.28M
3.73%
76.96M
21.61%
101.37M
31.72%
105.04M
3.62%
105.87M
0.79%
129.86M
22.66%
average payables
9.22M
-
9.24M
0.27%
10.61M
14.75%
10.59M
0.17%
10.98M
3.71%
12.73M
15.91%
13.38M
5.12%
14.18M
5.95%
13.37M
5.72%
18.84M
40.92%
27.67M
46.89%
average receivables
34.42M
-
39.36M
14.36%
42.39M
7.68%
46.58M
9.88%
52.07M
11.78%
63.31M
21.59%
66.50M
5.04%
59.84M
10.02%
63.06M
5.39%
85.15M
35.02%
103.33M
21.36%
book value per share
6.72
-
7.68
14.36%
8.62
12.11%
9.17
6.41%
10.08
9.91%
11.34
12.55%
13.00
14.68%
14.07
8.17%
16.77
19.20%
20.13
20.06%
21.75
8.04%
capex per share
-1.21
-
-0.30
75.28%
-0.65
117.71%
-0.74
13.90%
-0.67
8.84%
-0.90
33.17%
-0.75
16.36%
-0.41
45.69%
-0.41
0.59%
-0.51
24.88%
capex to depreciation
-5.99
-
-1.28
78.56%
-2.48
92.85%
-3.28
32.35%
-2.23
31.87%
-1.32
40.66%
-0.76
42.64%
-0.46
39.66%
-0.32
31.06%
-0.40
25.71%
capex to operating cash flow
-0.84
-
-0.11
86.84%
-0.26
138.93%
-0.44
67.46%
-0.20
54.97%
-0.29
47.58%
-0.17
41.99%
-0.10
40.96%
-0.06
42.17%
-0.08
40.25%
capex to revenue
-0.11
-
-0.03
78.04%
-0.05
86.86%
-0.05
8.74%
-0.04
19.23%
-0.05
22.51%
-0.04
24.37%
-0.02
45.44%
-0.02
15.28%
-0.02
7.37%
cash per share
1.10
-
2.73
149.29%
2.70
1.25%
1.71
36.71%
3.00
75.38%
2.61
13.04%
3.66
40.66%
3.94
7.44%
7.09
80.19%
8.36
17.80%
8.41
0.64%
days of inventory on hand
281.46
-
242.19
13.95%
263.15
8.65%
333.20
26.62%
314.55
5.60%
293.56
6.67%
410.24
39.75%
537.02
30.91%
366.12
31.82%
391.90
7.04%
177.76
54.64%
days payables outstanding
74.29
-
55.69
25.03%
71.92
29.14%
47.44
34.03%
67.82
42.96%
54.89
19.07%
67.54
23.05%
64.49
4.51%
49.63
23.04%
83.88
69.00%
37.74
55.00%
days sales outstanding
74.37
-
68.06
8.49%
65.46
3.81%
67.15
2.59%
68.80
2.46%
80.01
16.29%
63.60
20.52%
58.90
7.38%
59.96
1.79%
76.31
27.27%
64.01
16.12%
debt to assets
0.03
-
0.05
83.46%
0.03
52.67%
0.01
66.37%
0.04
384.13%
0.03
33.48%
0.01
51.87%
0.02
63.71%
debt to equity
0.04
-
0.08
93.87%
0.04
54.62%
0.01
68.78%
0.06
410.18%
0.04
36.77%
0.02
47.64%
0.03
55.34%
dividend yield
0.02
-
0.01
27.27%
0.03
74.90%
0.02
11.32%
0.02
9.21%
0.03
26.45%
0.01
65.55%
0.01
3.98%
0.01
26.01%
0.02
99.00%
earnings yield
0.03
-
0.03
17.75%
0.04
29.19%
0.03
27.36%
0.04
25.22%
0.05
32.56%
0.02
62.29%
0.02
16.10%
0.01
11.21%
0.03
99.33%
0.03
1.82%
enterprise value
989.30M
-
959.67M
2.99%
961.63M
0.20%
1.31B
36.71%
1.25B
4.67%
1.14B
9.39%
3.80B
234.52%
4.47B
17.80%
6.58B
47.02%
4.07B
38.18%
3.77B
7.29%
enterprise value over ebitda
25.20
-
20.17
19.95%
16.65
17.48%
21.74
30.60%
17.66
18.77%
13.15
25.53%
37.19
182.79%
42.59
14.52%
51.70
21.37%
25.83
50.04%
24.31
5.88%
ev to operating cash flow
37.99
-
19.61
48.38%
21.53
9.81%
43.14
100.34%
20.34
52.85%
20.35
0.05%
47.26
132.19%
60.36
27.73%
51.65
14.43%
35.83
30.62%
32.55
9.17%
ev to sales
5.20
-
4.48
13.82%
3.85
14.12%
5.00
30.10%
4.23
15.42%
3.52
16.95%
10.64
202.75%
12.56
18.03%
15.75
25.34%
8.36
46.88%
7.16
14.35%
free cash flow per share
0.23
-
2.41
937.61%
1.81
24.58%
0.94
48.41%
2.72
190.41%
2.16
20.42%
3.66
69.33%
3.65
0.27%
6.57
79.98%
5.71
13.17%
6.33
10.94%
free cash flow yield
0.00
-
0.04
937.61%
0.03
24.58%
0.01
61.14%
0.04
198.47%
0.03
11.72%
0.02
48.22%
0.01
15.00%
0.02
21.94%
0.02
38.13%
0.03
19.77%
graham net net
1.17
-
1.85
58.37%
2.37
28.20%
2.56
8.10%
3.28
27.91%
3.82
16.52%
3.25
14.96%
4.51
38.84%
7.26
60.91%
9.37
29.05%
10.28
9.71%
graham number
14.89
-
17.28
16.04%
20.79
20.35%
21.06
1.29%
24.37
15.72%
28.26
15.97%
33.61
18.92%
34.68
3.19%
43.34
24.99%
53.16
22.65%
52.70
0.88%
income quality
0.98
-
1.57
59.59%
1.10
29.47%
0.78
29.45%
1.29
66.14%
0.98
24.48%
1.14
16.92%
1.07
6.55%
1.40
31.15%
1.00
28.94%
1.12
12.05%
intangibles to total assets
0.08
-
0.07
17.25%
0.07
1.57%
0.08
9.92%
0.06
16.32%
0.15
127.20%
0.11
22.95%
0.09
16.76%
0.07
20.85%
0.07
0.12%
0
100%
interest coverage
9.84
-
interest debt per share
0.28
-
0.61
121.70%
0.31
49.12%
0.10
66.78%
0.58
460.73%
0.41
28.83%
0.25
39.95%
0.42
68.02%
0.73
-
inventory turnover
1.30
-
1.51
16.21%
1.39
7.96%
1.10
21.02%
1.16
5.93%
1.24
7.15%
0.89
28.44%
0.68
23.61%
1.00
46.68%
0.93
6.58%
2.05
120.46%
invested capital
0.04
-
0.08
93.87%
0.04
54.62%
0.01
68.78%
0.06
410.18%
0.04
36.77%
0.02
47.64%
0.03
55.34%
market cap
1.01B
-
1.01B
0.00%
1.01B
0.14%
1.35B
33.16%
1.31B
2.83%
1.18B
9.53%
3.87B
226.74%
4.55B
17.63%
6.71B
47.54%
4.22B
37.10%
3.91B
7.22%
net current asset value
58.17M
-
70.56M
21.30%
86.88M
23.13%
96.60M
11.19%
110.65M
14.54%
127.57M
15.29%
129.25M
1.32%
156.81M
21.32%
209.31M
33.47%
270.93M
29.44%
283.79M
4.75%
net debt to ebitda
-0.51
-
-1.04
105.72%
-0.85
18.56%
-0.51
39.34%
-0.77
49.24%
-0.55
28.27%
-0.65
18.81%
-0.68
4.71%
-1.02
48.70%
-0.97
4.73%
-0.93
3.82%
net income per share
1.47
-
1.73
17.75%
2.23
29.19%
2.15
3.59%
2.62
21.84%
3.13
19.49%
3.86
23.32%
3.80
1.55%
4.98
31.05%
6.24
25.30%
5.67
9.06%
operating cash flow per share
1.44
-
2.70
87.91%
2.46
8.88%
1.68
31.98%
3.39
102.43%
3.06
9.77%
4.41
44.19%
4.06
8.00%
6.98
71.88%
6.21
10.96%
6.33
1.90%
payables turnover
4.91
-
6.55
33.39%
5.08
22.56%
7.69
51.59%
5.38
30.05%
6.65
23.57%
5.40
18.73%
5.66
4.72%
7.35
29.94%
4.35
40.83%
9.67
122.22%
receivables turnover
4.91
-
5.36
9.28%
5.58
3.96%
5.44
2.52%
5.30
2.40%
4.56
14.01%
5.74
25.81%
6.20
7.97%
6.09
1.76%
4.78
21.42%
5.70
19.22%
research and ddevelopement to revenue
0.04
-
0.03
11.18%
0.04
20.86%
0.05
25.68%
0.05
5.84%
0.04
19.67%
0.04
1.67%
0.06
60.14%
0.05
18.59%
0.04
18.18%
0.06
36.97%
return on tangible assets
0.17
-
0.17
4.08%
0.20
20.33%
0.20
1.65%
0.20
3.77%
0.25
22.50%
0.24
4.93%
0.22
6.10%
0.24
9.96%
0.26
4.74%
0.21
19.56%
revenue per share
10.51
-
11.84
12.57%
13.79
16.51%
14.44
4.74%
16.30
12.86%
17.72
8.70%
19.60
10.58%
19.51
0.45%
22.89
17.34%
26.62
16.31%
28.77
8.06%
roe
0.22
-
0.22
2.96%
0.26
15.23%
0.23
9.39%
0.26
10.85%
0.28
6.16%
0.30
7.54%
0.27
8.99%
0.30
9.94%
0.31
4.36%
0.26
15.83%
roic
0.20
-
0.20
0.98%
0.24
18.39%
0.24
2.60%
0.24
1.03%
0.26
9.47%
0.29
8.56%
0.27
4.77%
0.29
5.65%
0.30
3.74%
0.25
17.32%
sales general and administrative to revenue
0.31
-
0.31
0.49%
0.31
2.38%
0.33
7.71%
0.32
2.66%
0.29
8.71%
0.31
5.04%
0.30
2.66%
0.29
3.14%
0.27
7.34%
shareholders equity per share
6.72
-
7.68
14.36%
8.62
12.11%
9.17
6.41%
10.08
9.91%
11.34
12.55%
13.00
14.68%
14.07
8.17%
16.77
19.20%
20.13
20.06%
21.75
8.04%
stock based compensation to revenue
tangible asset value
107.51M
-
124.97M
16.24%
140.72M
12.60%
149.88M
6.51%
166.70M
11.22%
166.98M
0.17%
198.69M
18.99%
224.16M
12.82%
275.88M
23.07%
331.62M
20.20%
397.94M
20.00%
tangible book value per share
5.94
-
6.90
16.24%
7.76
12.45%
8.24
6.17%
9.18
11.37%
9.16
0.20%
10.91
19.09%
12.28
12.53%
15.11
23.12%
18.16
20.13%
21.75
19.79%
working capital
65.93M
-
83.68M
26.93%
93.89M
12.20%
99.15M
5.61%
121.15M
22.18%
135.07M
11.49%
157.05M
16.28%
186.31M
18.63%
228.89M
22.86%
286.07M
24.98%
297.28M
3.92%

All numbers in (except ratios and percentages)